XML 30 R20.htm IDEA: XBRL DOCUMENT v3.22.0.1
Fair Value Measurements (Tables)
12 Months Ended
Dec. 31, 2021
Fair Value Measurements  
Schedule of company's assets and liabilities that are measured at fair value on a recurring basis

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

Fair Value Measured as of December 31, 2021

​

    

Level 1

    

Level 2

    

Level 3

    

Total

Assets:

 

​

  

 

​

  

 

​

  

 

​

  

Cash and Investments held in Trust Account

​

$

414,111,439

​

$

—

​

$

—

​

$

414,111,439

Liabilities:

​

 

  

​

 

  

​

 

  

​

 

  

Derivative liabilities - public warrants

​

​

14,076,000

​

​

—

​

​

—

​

​

14,076,000

Derivative liabilities - private placement warrants

​

​

—

​

​

7,534,400

​

​

—

​

​

7,534,400

Derivative liabilities - forward purchase agreement

​

​

—

​

​

—

​

​

2,820,000

​

​

2,820,000

Total liabilities

​

$

14,076,000

​

$

7,534,400

​

$

2,820,000

​

$

24,430,400

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

Fair Value Measured as of December 31, 2020

​

    

Level 1

    

Level 2

    

Level 3

    

Total

Assets:

 

​

  

 

​

  

 

​

  

 

​

  

Cash and Investments held in Trust Account

​

$

414,020,525

​

$

—

​

$

—

​

$

414,020,525

Liabilities:

​

 

  

​

 

  

​

 

  

​

 

  

Derivative liabilities - public warrants

​

​

—

​

​

—

​

​

21,390,000

​

​

21,390,000

Derivative liabilities - private placement warrants

​

​

—

​

​

—

​

​

11,449,330

​

​

11,449,330

Derivative liabilities - forward purchase agreement

​

​

—

​

​

—

​

​

7,692,950

​

​

7,692,950

Total liabilities

​

$

—

​

$

—

​

$

40,532,280

​

$

40,532,280

Schedule of key assumptions used of estimate the fair value

​

​

​

​

​

​

​

​

​

​

​

As of

​

As of

 

​

​

December 31,

​

December 31, 

 

​

    

2021

    

2022

 

Share price, used in warrant valuations

​

$

10.02

​

​

n/a

​

Unit price, used in forward valuation

​

$

10.54

​

$

10.20

​

Exercise price, warrants

​

$

11.50

​

 

n/a

​

Exercise price, forward

​

$

10.00

​

$

10.00

​

Term (in years), used in warrant valuations

​

​

6.00

​

​

n/a

​

Term (in years), used in forward valuation

​

​

0.96

​

​

0.25

​

Volatility

​

 

21.00

%  

 

15.5

%

Risk-free interest rate, used in warrant valuations

​

 

0.50

%  

 

n/a

​

Risk-free interest rate, used in forward valuation

​

 

0.10

%  

 

1.28

%

Expected dividends

​

​

n/a

​

​

n/a

​

Schedule of change in the fair value of the derivative liabilities

​

​

​

​

​

December 31, 2020 - Beginning of Period

    

​

​

Warrant Liabilities - Public

​

$

21,390,000

Warrant Liabilities - Private

​

 

11,449,330

Forward Purchase agreement

​

 

7,692,950

December 31, 2020

​

$

40,532,280

Change in fair value of warrant liabilities - Public

​

 

(7,314,000)

Change in fair value of warrant liabilities - Private

​

 

(3,914,930)

Change in fair value of forward purchase agreement

​

 

(4,872,950)

December 31, 2021

​

$

24,430,400

​

​

​

​

​

Level 3 derivative liabilities at December 31, 2020

    

$

40,532,280

Transfers from Level 3

​

​

(32,839,330)

Change in fair value

​

 

(6,935,120)

Level 3 derivative liabilities at March 31, 2021

​

​

757,830

Change in fair value

​

​

(159,200)

Level 3 derivative liabilities at June 30, 2021

​

​

598,630

Change in fair value

​

​

2,201,370

Level 3 derivative liabilities at September 30, 2021

​

​

2,800,000

Change in fair value

​

​

20,000

Level 3 derivative liabilities at December 31, 2021

​

$

2,820,000